Dantrium is a Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by Par Pharmaceutical, Inc.. The primary component is Dantrolene Sodium.
| Product ID | 42023-123_44e02603-a1bb-439b-9b74-aa90bab5f472 |
| NDC | 42023-123 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Dantrium |
| Generic Name | Dantrolene Sodium |
| Dosage Form | Injection |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2009-04-20 |
| Marketing Category | NDA / NDA |
| Application Number | NDA018264 |
| Labeler Name | Par Pharmaceutical, Inc. |
| Substance Name | DANTROLENE SODIUM |
| Active Ingredient Strength | 20 mg/60mL |
| Pharm Classes | Decreased Striated Muscle Contraction [PE],Decreased Striated Muscle Tone [PE],Skeletal Muscle Relaxant [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2009-04-20 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA018264 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2009-04-20 |
| Ingredient | Strength |
|---|---|
| DANTROLENE SODIUM | 20 mg/60mL |
| SPL SET ID: | 4df35098-8702-46be-ac67-30cfdf1aa570 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 42023-123 | Dantrium | dantrolene sodium |
| 42023-124 | Dantrium | dantrolene sodium |
| 42023-125 | Dantrium | dantrolene sodium |
| 0115-4411 | Dantrolene Sodium | Dantrolene Sodium |
| 0115-4422 | Dantrolene Sodium | Dantrolene Sodium |
| 0115-4433 | Dantrolene Sodium | Dantrolene Sodium |
| 0527-3219 | Dantrolene Sodium | dantrolene sodium |
| 0527-3220 | Dantrolene Sodium | dantrolene sodium |
| 0527-3221 | Dantrolene Sodium | dantrolene sodium |
| 0904-7211 | Dantrolene Sodium | Dantrolene Sodium |
| 42023-144 | dantrolene sodium | dantrolene sodium |
| 49884-362 | dantrolene sodium | dantrolene sodium |
| 49884-363 | dantrolene sodium | dantrolene sodium |
| 49884-364 | dantrolene sodium | dantrolene sodium |
| 50268-217 | Dantrolene Sodium | Dantrolene Sodium |
| 55154-7140 | Dantrolene Sodium | Dantrolene Sodium |
| 63629-2168 | dantrolene sodium | dantrolene sodium |
| 63629-2169 | dantrolene sodium | dantrolene sodium |
| 63629-2170 | dantrolene sodium | dantrolene sodium |
| 64850-840 | Dantrolene Sodium | dantrolene sodium |
| 64850-841 | Dantrolene Sodium | dantrolene sodium |
| 64850-842 | Dantrolene Sodium | dantrolene sodium |
| 68084-300 | Dantrolene Sodium | Dantrolene Sodium |
| 27505-003 | Revonto | dantrolene sodium |
| 42367-540 | RYANODEX | dantrolene sodium |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() DANTRIUM 85892501 4432295 Live/Registered |
PAR PHARMACEUTICAL, INC. 2013-04-02 |
![]() DANTRIUM 73418728 1277831 Live/Registered |
Eaton Laboratories, Inc. 1983-03-24 |
![]() DANTRIUM 72387314 0937430 Live/Registered |
NORWICH PHARMACAL COMPANY, THE 1971-03-24 |